Lemos Bouzas MX, Esparza Olcina MJ. Evid Pediatr. 2023;19:19
Artículo original: Naveed Z, Li J, Spencer M, Wilton J, Naus M, Velásquez García HA, et al. Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study. CMAJ. 2022;194:E1529-36.
Fraile Astorga G, Ochoa Sangrador C. Evid Pediatr. 2022;18:18
Artículo original: June Choe Y, Yi S, Hwang I, Kim J, Park YJ, Cho E, et al. Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents. Vaccine. 2022;40:691-4.
Ruiz-Canela Cáceres J, Rodríguez-Salinas Pérez E. Evid Pediatr. 2021;17:12
Artículo original: Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99-111.
Flores Villar S, Ortega Páez E. Evid Pediatr. 2020;16:15
Artículo original: Science M, Savage R, Severini A, McLachlan E, Hughes SL, Arnold C, et al. Measles Antibody levels in young infants. Pediatrics. 2019;144:e20190630.
Ochoa Sangrador C, Andrés de Llano JM. Evid Pediatr. 2020;16:17
Artículo original: Biswal S, Reynales H, Sáez-Llorens X, López P, Borja-Tabora C, Kosalaraksa P, et al. Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents. N Engl J Med. 2019;381:2009-2019.
Ruiz-Canela Cáceres J, García Vera C. Evid Pediatr. 2020;16:26
Artículo original: Nic Lochlainn LM, de Gier B, van der Maas N, van Binnendijk R, Strebel PM, Goodman T, et al. Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19:1246-54.